CONTACT
+91 80 2808 2808
info@biocon.com
Generics_Banner-biocon
Biocon  /  Products  /  Generics

GENERICS

Generic Formulations and API products are listed below.

GENERIC FORMULATIONS

Sl. No Molecule Name Status
1 Rosuvastatin Commercial (United States, Europe)
2 Simvastatin Commercial (United States)
3 Atorvastatin Commercial (United States)
4 Fingolimod Approved (United States, Europe)
5 Dapagliflozin Tentative Approval (United States)
6 Pemetrexed Tentative Approval (United States)
7 Tacrolimus Commercial (United States)
8 Everolimus (RLD Affinitor) Commercial (United States), Approved (Europe)
9 Pravastatin Commercial (United States)
10 Labetalol Commercial (United States)
11 Esomeprazole Commercial (United States)
12 Posaconazole Commercial (United States)

API

Cardiology
Sl. No Molecule Name
1 Simvastatin
2 Pravastatin
3 Atorvastatin
4 Rosuvastatin
5 Fluvastatin
6 Dabigatran
7 Sacubitril/Valsartan
8 Apixaban
9 Rivaroxaban
Anti-Diabetics
Sl. No Molecule Name
1 Vildagliptin
2 Linagliptin
3 Sitagliptin (various salts)
4 Dapagliflozin (different solvate forms)
5 Empagliflozin
6 Repaglinide
7 Liraglutide
8 Semaglutide
Immunosuppressants
Sl. No Molecule Name
1 Tacrolimus
2 Sirolimus
3 Everolimus
4 Pimecrolimus
5 Mycophenolate Mofetil (MMF)
6 Mycophenolate Sodium (MPS)
Multiple Sclerosis
Sl. No Molecule Name
1 Glatiramer Acetate
2 Fingolimod
3 Teriflunomide
Anti-Cancer/Oncology
Sl. No Molecule Name
1 Dasatinib
2 Lenalidomide
3 Pazopanib
4 Erdafitinib
Other Key Products
Sl. No Molecule Name
1 Orlistat
2 Mirabegron
3 Posaconazole
4 Micafungin
5 Anidulafungin
6 Brinzolamide
Siddharth Mittal
KEY MANAGEMENT TEAM
PRESS RELEASES
KMS
OUR LEGACY
CORPORATE GOVERNANCE
SUSTAINABILITY
Share
Previous Next
Close
Test Caption
Test Description goes like this